Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Largajolli

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics|November 16, 2019
Correction to: Bayesian approach to investigate a two-state mixed model of COPD exacerbationsAnna Largajolli, Misba Beerahee, Shuying Yang
Journal of Pharmacokinetics and Pharmacodynamics|June 15, 2019
Bayesian approach to investigate a two-state mixed model of COPD exacerbationsAnna Largajolli, Misba Beerahee, Shuying Yang
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|February 1, 2013
Identification of the glucose minimal model by stochastic nonlinear-mixed effects methodsAnna Largajolli, Alessandra Bertoldo, Claudio Cobelli
The AAPS Journal|August 13, 2015
Visual Predictive Check in Models with Time-Varying Input FunctionAnna Largajolli, Alessandra Bertoldo, Marco Campioni, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 13, 2019
The integrated glucose insulin minimal model: An improved versionMoustafa M A Ibrahim, Anna Largajolli, Mats O Karlsson, et al.
Pharmaceutical Research|April 20, 2019
Translation Between Two Models; Application with Integrated Glucose Homeostasis ModelsMoustafa M A Ibrahim, Anna Largajolli, Maria C Kjellsson, et al.
The AAPS Journal|October 14, 2025
Effective Visualizations Using "vachette" to Assess and Communicate Pharmacometric Model ResultsJos Lommerse, Anna Largajolli, James Craig, et al.
Frontiers in Pharmacology|January 31, 2025
Impact of using time-averaged exposure metrics on binary endpoints in exposure-response analysesYu-Wei Lin, Anna Largajolli, A Yin Edwards, et al.
Clinical Pharmacology and Therapeutics|May 23, 2023
Response-Based Dosing for Ponatinib: Model-Based Analyses of the Dose-Ranging OPTIC StudyMichael J Hanley, Paul Diderichsen, Benjamin Rich, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 20, 2026
Combining Aggregate Data and Individual Patient Data in Model-Based Meta-Analysis: An Illustrative Case Study of Tofacitinib in Rheumatoid Arthritis PatientsThao-Nguyen Pham, Anna Largajolli, Maria Luisa Sardu, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Pharmacokinetics and Pharmacodynamics|November 16, 2019
Correction to: Bayesian approach to investigate a two-state mixed model of COPD exacerbationsAnna Largajolli, Misba Beerahee, Shuying Yang
Journal of Pharmacokinetics and Pharmacodynamics|June 15, 2019
Bayesian approach to investigate a two-state mixed model of COPD exacerbationsAnna Largajolli, Misba Beerahee, Shuying Yang
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|February 1, 2013
Identification of the glucose minimal model by stochastic nonlinear-mixed effects methodsAnna Largajolli, Alessandra Bertoldo, Claudio Cobelli
The AAPS Journal|August 13, 2015
Visual Predictive Check in Models with Time-Varying Input FunctionAnna Largajolli, Alessandra Bertoldo, Marco Campioni, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 13, 2019
The integrated glucose insulin minimal model: An improved versionMoustafa M A Ibrahim, Anna Largajolli, Mats O Karlsson, et al.
Pharmaceutical Research|April 20, 2019
Translation Between Two Models; Application with Integrated Glucose Homeostasis ModelsMoustafa M A Ibrahim, Anna Largajolli, Maria C Kjellsson, et al.
The AAPS Journal|October 14, 2025
Effective Visualizations Using "vachette" to Assess and Communicate Pharmacometric Model ResultsJos Lommerse, Anna Largajolli, James Craig, et al.
Frontiers in Pharmacology|January 31, 2025
Impact of using time-averaged exposure metrics on binary endpoints in exposure-response analysesYu-Wei Lin, Anna Largajolli, A Yin Edwards, et al.
Clinical Pharmacology and Therapeutics|May 23, 2023
Response-Based Dosing for Ponatinib: Model-Based Analyses of the Dose-Ranging OPTIC StudyMichael J Hanley, Paul Diderichsen, Benjamin Rich, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 20, 2026
Combining Aggregate Data and Individual Patient Data in Model-Based Meta-Analysis: An Illustrative Case Study of Tofacitinib in Rheumatoid Arthritis PatientsThao-Nguyen Pham, Anna Largajolli, Maria Luisa Sardu, et al.
Pageof 2